RhumbLine Advisers’s Bio-Path Holdings Inc BPTH Stock Holding History

RhumbLine Advisers’s Portfolio BPTH Stock Details BPTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-25	Closed	-$84K	–	2968
2017 Q1	$84K	Buy	25 +6	+32%	+$21.8K	﹤0.01%	2792
2016 Q4	$105K	Sell	19 -2	-10%	-$9.69K	﹤0.01%	2790
2016 Q3	$117K	Buy	21 +3	+17%	+$19.3K	﹤0.01%	2794
2016 Q2	$140K	Buy	+18	New	+$182K	﹤0.01%	2851
2015 Q2	–	Sell	-18	Closed	-$129K	–	3105
2015 Q1	$129K	Buy	18 +4	+29%	+$33.6K	﹤0.01%	2917
2014 Q4	$153K	Hold	14	–	–	﹤0.01%	2883
2014 Q3	$112K	Buy	14 +1	+8%	+$9.65K	﹤0.01%	2914
2014 Q2	$161K	Buy	+13	New	+$142K	﹤0.01%	2910

Other funds holding BPTH

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RCA

Rowland Carmichael Advisors Scottsdale, Arizona $316M AUM 18.07% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

RhumbLine Advisers's BPTH Position: Q2 2017 in Review

RhumbLine Advisers sold out of Bio-Path Holdings Inc (BPTH) in Q2 2017, closing a stake of 25 shares — an estimated $84K sold.

RhumbLine Advisers first reported a position in BPTH in Q2 2014 and held it in 8 quarters. The position peaked at $161K in Q2 2014. 33 funds tracked by Wall St. Rank hold BPTH as of Q2 2017.

RhumbLine Advisers reported no remaining Bio-Path Holdings Inc position as of Q2 2017 after selling out during the quarter.
RhumbLine Advisers sold 25 Bio-Path Holdings Inc shares in Q2 2017, an estimated $84K.
RhumbLine Advisers first reported a position in Bio-Path Holdings Inc in Q2 2014 and held it in 8 quarters.
RhumbLine Advisers's Bio-Path Holdings Inc position peaked at $161K in Q2 2014.
33 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2017.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.